ClinicalTrials.Veeva

Menu
F

Franco Felizarta, MD | Bakersfield, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

B/F/TAF
RDV
Tesamorelin
Cenicriviroc
PF-06865571
PF-07817883
ABBV-382
Ribavirin
Peginterferon
Sofosbuvir

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 15 total trials

A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382

Human immuno-deficiency virus (HIV) is the virus that causes Acquired Immuno-Deficiency Syndrome (AIDS). HIV disease is considered to be a chronic di...

Enrolling
Human Immuno-deficiency Virus (HIV) Disease
Drug: Budigalimab
Drug: ABBV-382

The goal of this clinical study is to learn how safe and effective it is to switch to an oral therapy of Bictegravir/Emtricitabine/Tenofovir (B/F/TAF...

Enrolling
HIV-1-infection
Drug: B/F/TAF

Trial sponsors

Gilead Sciences logo
Pfizer logo
AbbVie logo
Exact Sciences Corporation logo
Hologic logo
M
T
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems